FOXP3 and amyotrophic lateral sclerosis: Moreover, in fast-progressing patients with ALS, reduced (9, 10) and dysfunctional Tregs (11) were found compared to slowly progressing patients, and FoxP3 expression, their master regulator, inversely correlated with disease progression and survival.